Medical schools' attitudes and perceptions regarding the use of central institutional review boards

Academic Medicine

Volumn 79, Issue 7, 2004, Pages 644-651

  Loh, Evangeline D ^a   Meyer, Roger E ^a,b  

^a ASSOCIATION OF AMERICAN MEDICAL COLLEGES   (United States)

^b Best Practice Project Management Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE; INSTITUTIONAL REVIEW BOARD; MEDICAL EDUCATION; MEDICAL SCHOOL; PERCEPTION; POLICY; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 3042776740     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001888-200407000-00007     Document Type: Review

References (25)

1. Korn D. Central IRB information brief. AAMC Info Brief. 2002 January;23:1-3.
2. Heath E. Ethical and policy issues in research involving human participants 〈http://onlineethics.org/reseth/nbac/hheath.html〉. Accessed 15 July 2003. National Bioethics Advisory Commission, 2001.
3. Grob G. Institutional review boards: a time for reform. Presented before the House Committee on Government Reform and Oversight, 105th Congress, June 11, 1998.
4. Burnam WJ, Reves RR, Cohn DL, Schooley RT. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Ann Intern Med. 2001;134:152-7.
5. Moreno J, Caplan AL, Wolpe PR. Updating protections for human subjects involved in research. JAMA. 1998;280:1951-8.
6. Christian MC, Goldberg JL, Abrams JS, et al. A central institutional review board for multi-institutional trials. N Engl J Med. 2002;346:1405-8.
7. Levine RJ, Lasagna L. Demystifying central review boards: current options and future directions. IRB. 1998;22:1-8.
8. Bodenheimer T. Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med. 2000;342:1539-44.
9. Henderson L. Centralized AMCs growing steadily. CenterWatch. 1999;6:4-5.
10. Association of American Medical Colleges. For the Health of the Public: Ensuring the Future of Clinical Research, Vol. 1. Washington, DC: AAMC, January 2000.
11. Borfitz D. Reconstructing the 1RB system. CenterWatch. 2002;9:1-10.
12. Institutional Review Boards: The Emergence of Independent Boards. DHHS Publ No. OEI-01-97-00192. Washington, DC: Government Printing Office, 1998.
13. DeMilto L. Working with institutional review boards and informed consent. DIA Forum. 2002;July:16-20.
14. Institutional Review Boards: a time for reform. DHHS Publ No. OEI-01-97-00193. Washington, DC: Government Printing Office, 1998.
15. AdvaMed 〈http://www.advamed.org/solutions/reviewboards.shtml〉. Accessed 27 June 2003. Boston, MA: AdvaMed, 2003.
16. Western Institutional Review Board 〈http:// www.wirb.com/〉. Accessed 18 February 2003. Olympia, WA: Western IRB, 2003.
17. Bentsen T. AAHRPP announces accredited organization 〈http://www. aahrpp.org/nr_06-06-03.htm〉. Accessed July 2003. Washington, DC: AAHRPP, 2003.
18. Multicenter Academic Clinical Research Organization 〈http://ccs. wustl.edu/macro/aboutmacro.htm〉. Accessed 26 November 2002. St. Louis, MO: MACRO, 2002.
19. NCI: The Central Institutional Review Board Initiative 〈http://www.ncicirb.org/〈. Accessed 18 February 2003. Rockville, MD: NCI, 2003.
20. Lepay D. Director, Office Good Clinical Practice, U.S. Food and Drug Administration, Washington, DC. Speech presented at PhRMA AAMC Forum meeting, August 2, 2001.
21. Koski G. Director, Office Human Research Protection, U.S. Department of Health and Human Services, Washington, DC. Lecture presented at Addressing the Issues: Academic and Industry Perspectives on Clinical Trials, August 2, 2001.
22. Humpreys K, Trafton J, Wagner TJ. The cost of institutional review board procedures in multicenter observational research. Ann Intern Med. 2003;139:77.
23. McWilliams R, Hoover-Fong J, Hamosh A, Beck S, Beaty T, Cutting G. Problematic variation in local institutional review of a multicenter genetic epidemiology study. JAMA. 2003;290:360-6.
24. Society of Pediatric Research and American Pediatric Society statement to the Institute of Medicine Committee on clinical research involving children participation and protection in clinical research 〈http://www.aps-spr.org/ Public_Policy/2003_Docs/lON0709.htm〉Accessed 4 August 2003. Washington, DC: APS-SPR, 2003.
25. McDaniel D, Baker M, Lansink J. 1RB accreditation and human subject protection. Appl Clin Trials 2002;January:32-8.